The Aartech Solonics share price forecast for the next 3 years points to a scenario range of Rs 57 to Rs 94 by 2030, driven by India’s power infrastructure capex and demand for specialised power electronics and automation products and sector tailwinds.

The Zaggle Prepaid Ocean Services share price forecast for the next 3 years points to a scenario range of Rs 260 to Rs 425 by 2030, driven by rising corporate adoption of digital spend management platforms and expansion of its SaaS plus fintech offering and sector tailwinds.

The Sun Pharma Advanced Research Company share price forecast for the next 3 years points to a scenario range of Rs 325 to Rs 545 by 2030, driven by progress on its novel drug pipeline and out-licensing deals for proprietary drug delivery technologies and sector tailwinds.

The Tata Motors Passenger Vehicles share price forecast for the next 3 years points to a scenario range of Rs 425 to Rs 720 by 2030, driven by EV market leadership in India and sector tailwinds.

The ZF Commercial Vehicle Control Systems India share price forecast for the next 3 years points to a scenario range of Rs 2,770 to Rs 4,540 by 2030, driven by rising safety regulation adoption in commercial vehicles and sector tailwinds.

The Ujjivan Small Finance Bank share price forecast for the next 3 years points to a scenario range of Rs 80 to Rs 130 by 2030, driven by diversification away from unsecured microfinance toward secured retail lending and steady deposit franchise growth and sector tailwinds.

The Tata Capital share price forecast for the next 3 years points to a scenario range of Rs 430 to Rs 700 by 2030, driven by the Tata Group brand and low cost funding access and sector tailwinds.

The 20 Microns share price forecast for the next 3 years points to a scenario range of Rs 240 to Rs 395 by 2030, driven by rising demand for specialty minerals from paints and plastics industries and capacity expansion in value added products and sector tailwinds.

The Yes Bank share price forecast for the next 3 years points to a scenario range of Rs 26 to Rs 43 by 2030, driven by continued balance sheet clean up and sector tailwinds.

The Suven Life Sciences share price forecast for the next 3 years points to a scenario range of Rs 445 to Rs 755 by 2030, driven by positive clinical trial readouts for its CNS pipeline and sector tailwinds.